Xiang Guo

5.7k total citations
122 papers, 2.8k citations indexed

About

Xiang Guo is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Xiang Guo has authored 122 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Otorhinolaryngology, 59 papers in Oncology and 49 papers in Surgery. Recurrent topics in Xiang Guo's work include Head and Neck Cancer Studies (72 papers), Head and Neck Surgical Oncology (31 papers) and Viral-associated cancers and disorders (16 papers). Xiang Guo is often cited by papers focused on Head and Neck Cancer Studies (72 papers), Head and Neck Surgical Oncology (31 papers) and Viral-associated cancers and disorders (16 papers). Xiang Guo collaborates with scholars based in China, United States and Sweden. Xiang Guo's co-authors include Ming‐Huang Hong, Yan‐Qun Xiang, Xing Lv, Hai-Qiang Mai, Chao-Nan Qian, Wei‐Xiong Xia, Ling Guo, Hu L, Ming‐Yuan Chen and Chong Zhao and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xiang Guo

119 papers receiving 2.7k citations

Peers

Countries citing papers authored by Xiang Guo

Since Specialization

Citations

This map shows the geographic impact of Xiang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Guo more than expected).

Fields of papers citing papers by Xiang Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Guo. The network helps show where Xiang Guo may publish in the future.

Co-authorship network of co-authors of Xiang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang Guo. A scholar is included among the top collaborators of Xiang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang Guo. Xiang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cisplatin-induced WWP1-eccDNA expression contributes to ovarian cancer resistance 2025 ·Advances in Clinical and Experimental Medicine ·(unknown), Li Han, Xiang Guo, (unknown), Hui Zhang, Kun Guo, Yi Tu, Ruifang Li	1
2	1321O Concurrent chemoradiotherapy with/without adjuvant capecitabine in locoregionally advanced nasopharyngeal carcinoma: A randomized controlled phase III trial 2025 ·Annals of Oncology ·Jingjing Miao, Chan Xiang, Liu C, Yi Guo, Xiang Guo, (unknown), Jing Zhang, Li Lu, (unknown), Hai‐Qiang Mai, Lijun Wang, Chong Zhao	0
3	High-rate, long-lifespan, sustainable potassium-ion batteries enabled by non-fluorinated solvents 2025 ·Materials Science and Engineering R Reports ·Xiang Guo, Hongliang Xie, Pushpendra Kumar, Honghong Liang, Fei Zhao, Yuqi Wang, Tao Cai, Qian Li, Wandi Wahyudi, Hui Zhu, Jiao Yin, Zheng Ma, Jun Ming	5
4	Development of cell-permeable and plasma-stable peptidomimetic inhibitors against PSD-95/nNOS interaction as potential anti-ischemic stroke agents 2025 ·European Journal of Medicinal Chemistry ·Jiacheng Wang, Raymond Liang, Lu Zhang, Ya‐Zhen Qin, Xiang Guo, Han Ju, Jie Zhou, Mingxin Dong	0
5	Deformable mirror driven by piezoelectric thin film based on multi-electrode array 2024 ·Sensors and Actuators A Physical ·Xiang Guo, Hongbo Yin, Maoying Li, Isaku Kanno, (unknown), Shiping Jiang, (unknown), (unknown)	4
6	Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial 2024 ·Nature Communications ·Xun Cao, (unknown), (unknown), (unknown), Jiayu Zhou, Xi Chen, Yingying Huang, (unknown), Liang‐Ru Ke, Lujun Han, Wei‐Xiong Xia, Lin‐Quan Tang, (unknown), Hu L, Xiang Guo, Xing Lv	5
7	Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose 2023 ·BMC Cancer ·Yingying Huang, Jiayu Zhou, (unknown), Liang‐Ru Ke, Wei‐Xiong Xia, Xun Cao, (unknown), Ying Deng, Xi Chen, Lulu Zhang, (unknown), Xiang Guo, Xing Lv	2
8	Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma 2023 ·Lipids in Health and Disease ·Xi Chen, Yingxue Li, Xun Cao, Meng‐Yun Qiang, (unknown), Liang‐Ru Ke, (unknown), Yingying Huang, (unknown), Jiayu Zhou, Ying Deng, Lulu Zhang, (unknown), (unknown), (unknown), (unknown), Xiang Guo, Xing Lv	5
9	Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021) 2023 ·EClinicalMedicine ·Daneng Li, Yohann Loriot, Adam M. Burgoyne, James M. Cleary, Armando Santoro, (unknown), Santiago Ponce Aix, Ignacio Garrido‐Laguna, Ramu Sudhagoni, Xiang Guo, (unknown), (unknown)	6
10	Short‐term efficacy and long‐term survival of nasopharyngeal carcinoma patients with radiographically visible residual disease following observation or additional intervention: A real‐world study in China 2022 ·Laryngoscope Investigative Otolaryngology ·Yingying Huang, Xun Cao, (unknown), Jiayu Zhou, Xiang Guo, Xing Lv	4
11	Allelic shift in cis-elements of the transcription factor RAP2.12 underlies adaptation associated with humidity in Arabidopsis thaliana 2022 ·Science Advances ·Shangling Lou, Xiang Guo, Lian Liu, Yan Song, Lei Zhang, Yuanzhong Jiang, (unknown), Pengchuan Sun, Bao Liu, Shaofei Tong, Ningning Chen, Meng Liu, (unknown), (unknown), (unknown), (unknown), Huanhuan Liu, Michael J. Holdsworth, Jianquan Liu	32
12	Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis 2022 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Dongni Chen, Wen‐Ze Qiu, (unknown), Yingying Huang, Jiayu Zhou, (unknown), Yan‐Qun Xiang, Xiang Guo, Xing Lv	10
13	Embryonic erythropoiesis and hemoglobin switching require transcriptional repressor ETO2 to modulate chromatin organization 2020 ·Nucleic Acids Research ·Xiang Guo, (unknown), Ivan Krivega, Ryan Dale, Ann Dean	12
14	SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor 2016 ·Cancer Research ·Li-Sheng Zheng, (unknown), Yun Cao, Li-Xia Peng, Rui Sun, Ping Xie, (unknown), Dong‐Fang Meng, Dong-Hua Luo, Xiong Zou, Ming‐Yuan Chen, Hai-Qiang Mai, Ling Guo, Xiang Guo, Jian‐Yong Shao, Bi-Jun Huang, Wei Zhang, Chao-Nan Qian	46
15	Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma 2013 ·Chinese Journal of Cancer ·Huan-Xin Lin, Yi-Jun Hua, Qiu-Yan Chen, Dong-Hua Luo, Rui Sun, Fang Qiu, Hao-Yuan Mo, Hai-Qiang Mai, Xiang Guo, (unknown), Ming‐Huang Hong, Ling Guo	23
16	Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis 2013 ·Chinese Journal of Cancer ·Ming‐Yuan Chen, Hai-Qiang Mai, Rui Sun, Xiang Guo, (unknown), Ming‐Huang Hong, Yi-Jun Hua	38
17	A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma 2012 ·Oral Oncology ·Pei‐Yu Huang, Ka-Jia Cao, Xiang Guo, Hao-Yuan Mo, Ling Guo, Yan‐Qun Xiang, (unknown), Fang Qiu, Su-Mei Cao, Ying Guo, Li Zhang, (unknown), Rui Sun, Qiu-Yan Chen, Dong-Hua Luo, Yi-Jun Hua, Hai-Qiang Mai, Ming‐Huang Hong	58
18	Fluctuations of Epstein-Barr Virus Serological Antibodies and Risk for Nasopharyngeal Carcinoma: A Prospective Screening Study with a 20-Year Follow-Up 2011 ·PLoS ONE ·Su-Mei Cao, Zhiwei Liu, Wei-Hua Jia, Qi-Hong Huang, Qing Liu, Xiang Guo, (unknown), Weimin Ye, Ming‐Huang Hong	123
19	Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma 2009 ·Chinese Journal of Cancer ·Pei-Yu Huang, Hai‐Qiang Mai, Dong–Hua Luo, Fang Qiu, (unknown), Yan‐Qun Xiang, Qiuyan Chen, Li Zhang, Rui Sun, Kajia Cao, Ling Guo, (unknown), (unknown), Xiang Guo, Feng Zhang	11
20	Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma 2009 ·The Laryngoscope ·Ming‐Yuan Chen, Weiping Wen, Xiang Guo, Ankui Yang, Chao‐Nan Qian, Yi‐Jun Hua, Xiang‐Bo Wan, (unknown), (unknown), Ming‐Huang Hong	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact